DD283836A5 - Verfahren zur bildung von antigenen hbv-teilchen - Google Patents

Verfahren zur bildung von antigenen hbv-teilchen Download PDF

Info

Publication number
DD283836A5
DD283836A5 DD89327953A DD32795389A DD283836A5 DD 283836 A5 DD283836 A5 DD 283836A5 DD 89327953 A DD89327953 A DD 89327953A DD 32795389 A DD32795389 A DD 32795389A DD 283836 A5 DD283836 A5 DD 283836A5
Authority
DD
German Democratic Republic
Prior art keywords
gene
pres
isolated
vector
fragment
Prior art date
Application number
DD89327953A
Other languages
German (de)
English (en)
Inventor
Gregory P Thill
Original Assignee
��@���������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��@���������@�������k�� filed Critical ��@���������@�������k��
Publication of DD283836A5 publication Critical patent/DD283836A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DD89327953A 1988-04-25 1989-04-25 Verfahren zur bildung von antigenen hbv-teilchen DD283836A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18642188A 1988-04-25 1988-04-25

Publications (1)

Publication Number Publication Date
DD283836A5 true DD283836A5 (de) 1990-10-24

Family

ID=22684891

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89327953A DD283836A5 (de) 1988-04-25 1989-04-25 Verfahren zur bildung von antigenen hbv-teilchen

Country Status (17)

Country Link
EP (1) EP0339567A1 (pt)
JP (1) JPH0284176A (pt)
KR (1) KR890016175A (pt)
CN (1) CN1040053A (pt)
AU (1) AU605036B2 (pt)
DD (1) DD283836A5 (pt)
DK (1) DK196689A (pt)
FI (1) FI891941A (pt)
HU (1) HUT52556A (pt)
IL (1) IL89991A0 (pt)
IN (1) IN171656B (pt)
NO (1) NO891687L (pt)
NZ (1) NZ228774A (pt)
PL (1) PL279105A1 (pt)
PT (1) PT90359A (pt)
YU (1) YU85589A (pt)
ZA (1) ZA892886B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341074C (en) 1987-06-22 2000-08-08 Hans A. Thoma Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells
US6197548B1 (en) * 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
WO1992013951A1 (en) * 1991-02-04 1992-08-20 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of human serum albumin in methylotrophic yeast cells
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
JP2011115042A (ja) * 2008-03-13 2011-06-16 Hamamatsu Univ School Of Medicine ＨＢｓペプチド融合体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879231A (en) * 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
AP56A (en) * 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.

Also Published As

Publication number Publication date
KR890016175A (ko) 1989-11-28
CN1040053A (zh) 1990-02-28
FI891941A0 (fi) 1989-04-24
AU605036B2 (en) 1991-01-03
PT90359A (pt) 1989-11-10
NZ228774A (en) 1991-05-28
AU3328289A (en) 1989-11-02
EP0339567A1 (en) 1989-11-02
PL279105A1 (en) 1989-12-27
DK196689A (da) 1989-10-26
FI891941A (fi) 1989-10-26
DK196689D0 (da) 1989-04-24
NO891687D0 (no) 1989-04-24
HUT52556A (en) 1990-07-28
YU85589A (sh) 1992-07-20
JPH0284176A (ja) 1990-03-26
IN171656B (pt) 1992-12-05
NO891687L (no) 1989-10-26
IL89991A0 (en) 1989-12-15
ZA892886B (en) 1989-12-27

Similar Documents

Publication Publication Date Title
DE3586889T2 (de) Regulatorregion fuer die expression von heterologen genen in hefe.
DE68927921T2 (de) Expression von Hepatitis B S und preS2 Proteinen in methylotrophen Hefen
DE3485810T2 (de) Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.
DE3688831T2 (de) Herstellung von Hepatitis-B-Oberflächen-Antigen-(HBsAg) mittels Hefe.
DE3486206T2 (de) Expressionssysteme für Hefe mit PyK-Promotoren enthaltenden Vektoren und Synthese von Fremdproteinen.
DE3689411T2 (de) Methode zur erhöten Expression von Polypeptiden in Hefe des Gattung Pichia.
DE3789866T2 (de) DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung.
DE3587759T2 (de) Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion.
DE68928380T2 (de) Expression von menschlichen Serumalbumin in methylotrophischen Hefen
DD218118A5 (de) Verfahren zur herstellung eines hefe- oder nichthefepolypeptids
DD212982A5 (de) Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden
DE68919140T2 (de) Hühner-beta-Actin-Genpromoter enthaltender Vektor zur Expression eines erwünschten Gens.
DD284047A5 (de) Verfahren zur herstellung einer dna-sequenz, die fuer einen alkohol-oxidose-ii-regulationsbereich einer methylotrophen hefe kodiert
DE3689899T2 (de) Verfahren und hybridpromotor zur steuerung der exogenen gentranskription.
DD283836A5 (de) Verfahren zur bildung von antigenen hbv-teilchen
DE3878410T2 (de) Verfahren zur erhoehung von gen-expression.
DE3788592T2 (de) Plasmidvektor zur Expression im Bazillus, dessen Umwendung für die Klonierung des menschlichen Wachstumshormongens und Verfahren zur Produktion des Hormons.
DE4020181A1 (de) Neue promotorregion
DE69433222T2 (de) Mutanter AOX2-Promotor
DE3688643T2 (de) Für eine Variante des Elongationsfaktors 2 kodierende DNS-Sequenz.
DE69122940T2 (de) Von E-coli abgeleitete stromaufwärts gelegene, in Hefe wirksame, regulatorische Sequenzen
DE3687796T2 (de) Verkuerzter phosphoglycerat-kinase-promotor.
DE69121159T2 (de) Wirt-Vektor-System
DE3444495A1 (de) Herstellung eines multi-kopien-hefe-vektors
WO1993004180A1 (de) Verfahren zur gezielten genetischen veränderung von ashbya gossypii

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee